2009-2010 Schedule

The Cancer Pharmacology group at the UWCCC invites faculty, students and fellows, as well as representatives of local biotechnology companies, to attend a series of research seminars on translational cancer research dealing with anti-cancer target and drug discovery, pre-clinical studies and early clinical evaluation of anti-cancer therapies. Those interested in presenting should contact Michael Hoffmann.

September 10	BJ Kern Senior Vice President High Throughput Genomics, Inc. Precision Measurement of Gene Expression from FFPE Specimens Using Nuclease Protection Technology
October 8	Hasan Mukhtar UW Dept of Dermatology Cancer Chemoprevention: Could it be a success story for controlling cancer?
November 12	Arthur Polans UW Dept of Ophthalmology The Anti-Cancer Effects of Resveratrol
December 10	Andreas Friedl UW Dept of Pathology Stromal Fibroblasts - Regulators of Growth and Invasion in Breast Cancer
January 14	Wei Xu UW McArdle Laboratory Cancers modulated by environmental and nutritional estrogens
February 11	Hirak Basu UW Dept of Medicine Blocking specific biochemical pathway of metabolic oxidative stress to prevent prostate cancer
March 11	Emery Bresnick UW Dept of Pharmacology Human Leukemogenesis Via GATA Factor Dysregulation
April 8	Yongna Xing UW McArdle Laboratory Structural insights into PP2A regulation
May 13	Tim Bugni UW School of Pharmacy Marine Natural Product Libraries for Drug Discovery